Transdermal drug delivery in vitro using diffusion cells.
暂无分享,去创建一个
[1] Howard I. Maibach,et al. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods, Fourth Edition , 2005 .
[2] Robert L. Bronaugh. Methods for in Vitro Percutaneous Absorption , 1995 .
[3] J Kao,et al. Cutaneous metabolism of xenobiotics. , 1990, Drug metabolism reviews.
[4] P. Blondeel,et al. A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[5] J. Bouwstra,et al. Structure of the skin barrier and its modulation by vesicular formulations. , 2003, Progress in lipid research.
[6] S. M. Harrison,et al. Effects of freezing on human skin permeability , 1984, The Journal of pharmacy and pharmacology.
[7] Biana Godin,et al. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. , 2007, Advanced drug delivery reviews.
[8] G. P. Martin,et al. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. , 2007, Journal of pharmaceutical sciences.
[9] R. F. Fedors,et al. A method for estimating both the solubility parameters and molar volumes of liquids , 1974 .
[10] Hope Mj,et al. Liposomes. A perspective for dermatologists. , 1993 .
[11] J. Bos,et al. The 500 Dalton rule for the skin penetration of chemical compounds and drugs , 2000, Experimental dermatology.
[12] B. Kemppainen,et al. Methods for Skin Absorption , 1990 .
[13] B. Testa,et al. The skin as a drug-metabolizing organ. , 1978, Drug metabolism reviews.
[14] J. Heylings,et al. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.
[15] A. Sakr,et al. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. , 1989, Toxicology and applied pharmacology.
[16] B. Spiegeleer,et al. Quality analytics of internet pharmaceuticals , 2010, Analytical and bioanalytical chemistry.
[17] James N McDougal,et al. Skin absorption and human risk assessment. , 2002, Chemico-biological interactions.
[18] P Sartorelli,et al. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. , 2004, Regulatory toxicology and pharmacology : RTP.
[19] R. Bronaugh,et al. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. , 1985, Journal of pharmaceutical sciences.
[20] H. Maibach,et al. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery , 1989 .
[21] S. Hotchkiss,et al. Evaluation of Barrier Creams against Sulphur Mustard , 2002, Skin Pharmacology and Physiology.
[22] Geoffrey Lee,et al. Drug Permeation through Human Skin: I. Effects of Storage Conditions of Skin , 1982 .
[23] Eric Deconinck,et al. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds. , 2007, Bioorganic & medicinal chemistry.
[24] B. van Ravenzwaay,et al. A comparison between in vitro rat and human and in vivo rat skin absorption studies , 2004, Human & experimental toxicology.
[25] M. Bracher,et al. Percutaneous absorption of hair dyes : an interlaboratory comparison of in vivo and in vitro data with rat and pig , 1994 .
[26] J A Bouwstra,et al. Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.
[27] R. Scott,et al. Further validation of an in vitro method to reduce the need for in vivo studies for measuring the absorption of chemicals through rat skin. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[28] D Guest,et al. A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[29] T. Franz. Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.
[30] Howard I. Maibach,et al. Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .
[31] J. Bouwstra,et al. Water distribution and natural moisturizer factor content in human skin equivalents are regulated by environmental relative humidity. , 2008, The Journal of investigative dermatology.
[32] J. J. van de Sandt,et al. Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[33] Majella E Lane,et al. Skin penetration enhancers. , 2013, International journal of pharmaceutics.
[34] R H Guy,et al. Iontophoresis—Recent Developments * , 1998, The Journal of pharmacy and pharmacology.
[35] K. Vávrová,et al. Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[36] T. Redelmeier,et al. Skin Barrier: Principles of Percutaneous Absorption , 1996 .
[37] A. Watkinson. Dermal and Transdermal Drug Delivery , 2008 .
[38] Michael S Roberts,et al. Molecular size as the main determinant of solute maximum flux across the skin. , 2004, The Journal of investigative dermatology.
[39] M. Schäfer-Korting,et al. The Phenion® Full-Thickness Skin Model for Percutaneous Absorption Testing , 2009, Skin Pharmacology and Physiology.
[40] C. Hansen,et al. Permeability of commercial solvents through living human skin. , 1995, American Industrial Hygiene Association journal.
[41] Absorption Enhancers: Applications and Advances , 2012, The AAPS Journal.
[42] J. Weaver,et al. Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[43] J. Zbytovská,et al. Amphiphilic transdermal permeation enhancers: structure-activity relationships. , 2005, Current medicinal chemistry.
[44] Mark T D Cronin,et al. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. , 2002, Chemosphere.
[45] K. Sugibayashi,et al. Species differences in percutaneous absorption of nicorandil. , 1991, Journal of pharmaceutical sciences.
[46] R. Zendzian. Dermal absorption of pesticides in the rat. , 2000, AIHAJ : a journal for the science of occupational and environmental health and safety.
[47] Robert Langer,et al. Transdermal drug delivery , 2008, Nature Biotechnology.
[48] G. S. Hawkins,et al. Development of an in vitro model for determining the fate of chemicals applied to skin. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[49] H. Maibach,et al. Effects of Skin Occlusion on Percutaneous Absorption: An Overview , 2001, Skin Pharmacology and Physiology.
[50] Ian Colbeck,et al. Human Exposure to Pollutants via Dermal Absorption and Inhalation , 2010 .